GoodRx has raised $22.2M through multiple funding rounds, including two major Series B raises worth $10.3M and $9.45M, along with an earlier undisclosed Series B round led by Silver Lake. With backing from top investors such as Upfront Ventures, Highland Capital Partners, and SV Angel, GoodRx has grown into a leading provider of prescription price comparison tools. The company’s public status and strong revenue performance position it to further expand its consumer-facing healthcare solutions. GoodRx continues delivering transparent drug prices to millions of Americans.